Fulcrum Therapeutics (FULC) Change in Cash (2018 - 2026)

Fulcrum Therapeutics (FULC) has 9 years of Change in Cash data on file, last reported at -$147.3 million in Q1 2026.

• Change in Cash for Q1 2026 came in at -$147.3 million, down 818.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.1 million (up 262.63% YoY), and the FY2025 annual result was $139.3 million, up 325.3% from the prior year.
• Change in Cash declined to -$147.3 million in Q1 2026 per FULC's latest filing, from $150.5 million in the prior quarter.
• Over five years, Change in Cash peaked at $150.5 million in Q4 2025 and troughed at -$147.3 million in Q1 2026.
• A 5-year average of $879882.4 and a median of -$768000.0 in 2023 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2024 and 2026: Change in Cash jumped 6189.58% in 2024, then sank 818.5% in 2026.
• A 5-year view of Change in Cash shows it stood at -$55.8 million in 2022, then jumped by 91.91% to -$4.5 million in 2023, then tumbled by 219.19% to -$14.4 million in 2024, then soared by 1143.52% to $150.5 million in 2025, then tumbled by 197.88% to -$147.3 million in 2026.
• Business Quant data shows FULC's Change in Cash at -$147.3 million in Q1 2026, $150.5 million in Q4 2025, and $4.5 million in Q3 2025.